IMMUCELL CORP /DE/ Quarterly Operating Lease, Payments in USD from Q3 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Immucell Corp /De/ quarterly/annual Operating Lease, Payments history and growth rate from Q3 2022 to Q3 2024.
  • Immucell Corp /De/ Operating Lease, Payments for the quarter ending September 30, 2024 was $144K, a 107% increase year-over-year.
  • Immucell Corp /De/ Operating Lease, Payments for the twelve months ending September 30, 2024 was $550K.
  • Immucell Corp /De/ annual Operating Lease, Payments for 2023 was $249K, a 67.6% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $550K $144K +$74.6K +107% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $475K $144K +$113K +366% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $362K $144K +$114K +369% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $249K $117K Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $69.7K +$38.3K +122% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $31K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $30.7K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q3 2022 $31.5K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.